Smartdrug helps start-ups companies (biotech, life science, healthtech) navigating the complex world of drug development, increasing their chances of bringing the best drug to later clinical stages, partnering and finding an exit.

​

We have broad and deep experience across all modalities (oligonucleotides and RNA-based technologies, cell&gene, biologics, peptides, nanoparticles, small molecules), but not only...

​

What we do differently

​

The same rules that apply to one molecule, one modality, one biological system, one indication, do not apply to another one, so we will not give you "common practice", "standard FDA requirements" or defined processes. You will never hear from us "This is how is normally done" or "we have always done it this way".

We know every program has its own unique path to achieve the suitable set of data.

What we do for you is individually tailored to your science, development stage, specific technology and outlook (indication vs safety risk benefit, patients need, modality, delivery…)

​

We know how regulatory agencies, big Pharma, VC and private investors think, we can translate the untold, make sure there are no misunderstanding and the expectations of both parties are aligned for a win-win Outcome.

​

We analyse, understand, think holistically and deliver the best, concrete, implementable answer.

​

Forget what you think you know, with us you are going on a new Journey!

​

​